Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Government Resource

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. US Food and Drug Administration; FDA.

Save
Print
October 10, 2018
US Food and Drug Administration; FDA.
Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.
Save
Print
Cite
Citation

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. US Food and Drug Administration; FDA.